SCHEMBL4580321

SCHEMBL4580321

CC(=O)Oc1ccc(C(=O)N(N)c2cccc(C3=CC(=O)CC3)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GFER P55789 1/20 0.40
LMNA P02545 2/20 0.39
GAA P10253 1/20 0.39
TDP1 Q9NUW8 2/20 0.37
MAPT P10636 1/20 0.37
POLB P06746 2/20 0.36
ELANE P08246 1/20 0.36
HSD17B10 Q99714 1/20 0.36
ESR1 P03372 1/20 0.36
PGR P06401 1/20 0.36
CHRM2 P08172 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
AR P10275 1/20 0.36
CHRM1 P11229 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A3 Q01959 1/20 0.36
HPGD P15428 2/20 0.34
PKM P14618 1/20 0.34
HTT P42858 1/20 0.34
RECQL P46063 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4578367 0.81 GFER (0.39) GFERLMNAGAATDP1MAPT
SCHEMBL4579745 0.80 GFER (0.35) GFERLMNAGAATDP1MAPT
SCHEMBL4579942 0.76 LMNA (0.43) GFERLMNAGAATDP1MAPT
SCHEMBL1066509 0.76 HDAC3 (0.41) GFERLMNAGAATDP1MAPT
SCHEMBL4580491 0.74 LMNA (0.44) GFERLMNAGAATDP1MAPT
SCHEMBL4580317 0.70 HDAC2 (0.52) LMNAMAPTPKMMEN1KMT2A
SCHEMBL4578184 0.67 MEN1 (0.45) GFERLMNAGAATDP1MAPT
SCHEMBL7865528 0.64 KDM4E (0.69) GAAMAPTHPGDHTTHSD17B1
SCHEMBL28103467 0.64 HSD17B2 (0.55) HPGDHSD17B1HSD17B2MEN1KMT2A
SCHEMBL15258336 0.63 HSD17B1 (0.48) LMNAMAPTSLC6A3HPGDHSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2007720-B1 BENZAMIDE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC (CA) 2013-12-25 EP disclosed
US-8598168-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2013-12-03 US disclosed
US-20080132503-A1 Inhibitors of Histone Deacetylase METHYLGENE INC. (CA) 2008-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132503-A1 Inhibitors of Histone Deacetylase HDAC1, HDAC5, HDAC3 GFER 3966/4885LMNA 1922/4885GAA 210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.